144 related articles for article (PubMed ID: 38447209)
21. Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment.
Llovet JM; Vogel A; Madoff DC; Finn RS; Ogasawara S; Ren Z; Mody K; Li JJ; Siegel AB; Dubrovsky L; Kudo M
Cardiovasc Intervent Radiol; 2022 Apr; 45(4):405-412. PubMed ID: 35119481
[TBL] [Abstract][Full Text] [Related]
22. Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma.
Guo Y; Ren Y; Chen L; Sun T; Zhang W; Sun B; Zhu L; Xiong F; Zheng C
BMC Cancer; 2022 Mar; 22(1):270. PubMed ID: 35287627
[TBL] [Abstract][Full Text] [Related]
23. A Retrospective Study on Therapeutic Efficacy of Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors Plus Lenvatinib in Patients With Unresectable Hepatocellular Carcinoma.
Teng Y; Ding X; Li W; Sun W; Chen J
Technol Cancer Res Treat; 2022; 21():15330338221075174. PubMed ID: 35313780
[No Abstract] [Full Text] [Related]
24. Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: necessity for prospective randomized trial.
Yoshimi F; Nagao T; Inoue S; Kawano N; Muto T; Gunji T; Ohnishi S; Imawari M
Hepatology; 1992 Sep; 16(3):702-6. PubMed ID: 1324216
[TBL] [Abstract][Full Text] [Related]
25. [Resection or interventional treatment of hepatocellular carcinoma: which method for which patient?].
Lang H; Ricke J; Schlaak J
Dtsch Med Wochenschr; 2013 Sep; 138(36):1780-4. PubMed ID: 23943578
[No Abstract] [Full Text] [Related]
26. Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma.
Zhang S; Zhao Y; He L; Bo C; An Y; Li N; Ma W; Guo Y; Guo Y; Zhang C
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101851. PubMed ID: 34923180
[TBL] [Abstract][Full Text] [Related]
27. [Clinical analysis of the treatment:transcatheter arterial chemoembolization combined with sorafenib in advanced hepatocellular carcinoma].
Li Y; Huang JW; Lu LG; Shao PJ; Hu BS; Huang GM; Wei ZG; Zhang L
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(31):2187-92. PubMed ID: 21029658
[TBL] [Abstract][Full Text] [Related]
28. Successful hepatocellular carcinoma downstaging with transarterial chemoembolization followed by stereotactic radiotherapy.
Jacob R; Saddekni S; Dover L; DuBay DA
Liver Transpl; 2016 Apr; 22(4):547-51. PubMed ID: 26785388
[No Abstract] [Full Text] [Related]
29. Spinal cord injury subsequent to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Kim JH; Yeon JE; Jong YK; Seo WK; Cha IH; Seo TS; Park JJ; Kim JS; Bak YT; Byun KS
Dig Liver Dis; 2010 Jan; 42(1):67-70. PubMed ID: 19546038
[TBL] [Abstract][Full Text] [Related]
30. Combination of Neoadjuvant Transcatheter Arterial Chemoembolization and Orthotopic Liver Transplantation for the Treatment of Cirrhotomimetic Hepatocellular Carcinoma.
Habibollahi P; Shamchi SP; Tondon R; Ecker BL; Gade TP; Hunt S; Soulen MC; Furth EE; Levine MH; Nadolski G
J Vasc Interv Radiol; 2018 Feb; 29(2):237-243. PubMed ID: 29221923
[TBL] [Abstract][Full Text] [Related]
31. [Experience of the treatment following downstaging of larger hepatocellular carcinomas by transcathetheter hepatic arterial chemoembolization in 58 patients].
Jin X; Shi XJ; Wang MQ; Wei LX; Ye HY; Liang YR; Luo Y; Dong JH
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(14):950-5. PubMed ID: 21609544
[TBL] [Abstract][Full Text] [Related]
32. Major achievements in hepatocellular carcinoma.
Bruix J; Llovet JM
Lancet; 2009 Feb; 373(9664):614-6. PubMed ID: 19231618
[No Abstract] [Full Text] [Related]
33. Conversion Hepatectomy for Huge Hepatocellular Carcinoma With Arterioportal Shunt After Chemoembolization and Lenvatinib Therapy.
Sato N; Beppu T; Kinoshita K; Yuki H; Suyama K; Chiyonaga S; Motohara T; Komohara Y; Hara A; Akahoshi S
Anticancer Res; 2019 Oct; 39(10):5695-5701. PubMed ID: 31570469
[TBL] [Abstract][Full Text] [Related]
34. Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study.
Qu WF; Ding ZB; Qu XD; Tang Z; Zhu GQ; Fu XT; Zhang ZH; Zhang X; Huang A; Tang M; Tian MX; Jiang XF; Huang R; Tao CY; Fang Y; Gao J; Wu XL; Zhou J; Fan J; Liu WR; Shi YH
BJS Open; 2022 Sep; 6(5):. PubMed ID: 36125345
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of transarterial chemoembolization combined with lenvatinib, programmed death-1 inhibitor, and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis.
Lin LW; Yan LY; Ke K; Yang WZ; Lin JQ; Huang N
Brachytherapy; 2023; 22(6):858-871. PubMed ID: 37574351
[TBL] [Abstract][Full Text] [Related]
36. Liver tumors and loco-regional therapy.
Vogel W
Wien Med Wochenschr; 2013 Mar; 163(5-6):107-8. PubMed ID: 23456251
[No Abstract] [Full Text] [Related]
37. [A case of advanced hepatocellular carcinoma wherein readministration was made possible due to successful transcatheter arterial embolization for intratumoral hemorrhage during Lenvatinib administration].
Hara H; Nakano Y; Arai K; Kaneko Y; Sakaki K; Fukami Y; Ikemiyagi H; Yoshino K; Sakita S
Nihon Shokakibyo Gakkai Zasshi; 2022; 119(5):476-485. PubMed ID: 35545547
[TBL] [Abstract][Full Text] [Related]
38. Intra-arterial infusion of chemotherapy for advanced hepatocellular carcinoma: an Asian perspective.
Chan SL; Johnson P
Asia Pac J Clin Oncol; 2012 Jun; 8(2):111-4. PubMed ID: 22524569
[No Abstract] [Full Text] [Related]
39. Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study.
Fu Z; Li X; Zhong J; Chen X; Cao K; Ding N; Liu L; Zhang X; Zhai J; Qu Z
Hepatol Int; 2021 Jun; 15(3):663-675. PubMed ID: 33877527
[TBL] [Abstract][Full Text] [Related]
40. Case Report: Antiangiogenic Therapy Plus Immune Checkpoint Inhibitors Combined With Intratumoral Cryoablation for Hepatocellular Carcinoma.
Li X; Xu J; Gu X; Chen L; Wu Q; Li H; Bai H; Yang J; Qian J
Front Immunol; 2021; 12():740790. PubMed ID: 34733279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]